BeOne Medicines net profit more than triples to USD 384.71 million in Q3 2026
BeOne Medicines reported net profit of USD 384.71 million in the third quarter of 2026.
Related stories
Gildan cuts 2026 revenue outlook to $5.4B-$5.5B
M impact | EARNINGS | Nov 05, 2026, 11:28 AM UTC
Trulieve Cannabis Reports Q3 Adjusted Net Income of USD 18 Million
M impact | EARNINGS | Nov 05, 2026, 11:18 AM UTC
Gildan Activewear Q3 adjusted EBIT USD 396.2 million
M impact | EARNINGS | Nov 05, 2026, 11:18 AM UTC
ProFrac Reports Q3 Net Income
M impact | EARNINGS | Nov 05, 2026, 11:18 AM UTC
FS KKR Capital Reports Quarterly Net Investment Income of $0.46 Per Share
M impact | EARNINGS | Nov 05, 2026, 11:18 AM UTC
AtkinsRéalis Group Reports Q3 Adjusted EBITDA of CAD 331 Million
M impact | EARNINGS | Nov 05, 2026, 11:18 AM UTC